Scientists Announce Possible Breakthrough in Delaying Alzheimer’s
Research announced today is the first of its kind to suggest that anti-amyloid drugs can delay or even stop the progression ...
Anti-amyloid therapy may keep Alzheimer’s symptoms at bay in certain patients, study suggests
For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...
Volunteers with Down’s syndrome could help find Alzheimer’s drugs
And though drugs that have some effect on Alzheimer’s disease, dementia’s most common manifestation, have recently been ...
pharmaphorum6d
Lilly’s Alzheimer’s drug delayed as FDA seeks adcomm
However, around a quarter (24%) of patients had amyloid-related ... groups based on levels of tau protein, another Alzheimer’s biomarker, which showed that donanemab worked better in patients ...
pharmaphorum2d
Lilly's tau drug for Alzheimer's flunks phase 2 test
At the moment, there are no other tau-directed candidates ... Alzheimer's alongside the beta-amyloid plaques targeted by Lilly's recently approved Kisunla (donanemab) and Eisai/Biogen's Leqembi ...
Medical News Today8h
Anti-amyloid drug may help reduce the risk of early-onset Alzheimer's by 50%
An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...
Researchers find a hint at how to delay Alzheimer’s symptoms. Now they have to prove it
An experimental treatment appears to postpone Alzheimer's symptoms in some people genetically destined to get the disease at ...
Clinical Trials Arena on MSN10h
Roche’s discontinued Alzheimer’s drug shows signs of preventing onset
Investigators said that the OLE study showed Roche’s gantenerumab dropped the risk of developing symptoms by 50%.
Medscape4d
The Role Of Interleukin-1 In Neuroinflammation And Alzheimer Disease: An Evolving Perspective
Elevation of the proinflammatory cytokine Interleukin-1 (IL-1) is an integral part of the local tissue reaction to central nervous system (CNS) insult. The discovery of increased IL-1 levels in ...
Alzheimer's Society3d
DiADeM (Diagnosing Advanced Dementia Mandate)
DiADeM is a tool to support GPs in diagnosing dementia for people living with advanced dementia in a care home setting. It has been developed by the Yorkshire and Humber Dementia Strategic Clinical ...